AstraZeneca Paying Up To $2 Billion For Experimental Obesity Pill —As Weight Loss Drug Market Grows

The drug is similar to Ozempic, which is commonly used for diabetes and weight loss.

Source: Forbes.com Healthcare News - November 9, 2023 Category: Pharmaceuticals Authors: Ty Roush, Forbes Staff Tags: Business /business Innovation /innovation Healthcare /healthcare Breaking breaking-news topline Source Type: news